Literature DB >> 19465454

The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung.

Shanbeh Zienolddiny1, Vidar Skaug, Nina E Landvik, David Ryberg, David H Phillips, Richard Houlston, Aage Haugen.   

Abstract

Genome-wide association studies have provided evidence that common variation at 5p15.33 [telomerase reverse transcriptase (TERT)-cleft lip and palate transmembrane 1-like (CLPTM1L)], 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) influences lung cancer risk and cancer types with strong environmental risk factors. To independently validate these associations, we compared 5p15.33 (rs402710, rs401681), 6p21.33 (rs4324798) and 15q25.1 (rs1051730, rs16969968 and rs8034191) genotypes in 365 non-small cell lung cancer cases and 440 controls. Consistent with published data, variant genotypes of 5p15 (rs402710), 6p21 and 15q25 showed dose-dependent associations with lung cancer risk. To examine if variants influence the impact of environmental risk factors on lung carcinogenesis, we studied the relationship between genotype and levels of bulky aromatic/hydrophobic DNA adducts in lung tissue adjacent to tumor from 204 lung cancer cases. The risk allele of rs402710 (TERT-CLPTM1L locus) was associated with significantly higher levels of bulky aromatic/hydrophobic DNA adducts (P = 0.02). These data demonstrate a potential association between the TERT-CLPTM1L variant and levels of bulky DNA adducts measured by (32)P-postlabeling and hence a basis for susceptibility to the development of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465454     DOI: 10.1093/carcin/bgp131

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  53 in total

1.  Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck.

Authors:  Zhensheng Liu; Guojun Li; Sheng Wei; Jiangong Niu; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2010-08-28       Impact factor: 4.944

2.  Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study.

Authors:  Manuela Gago-Dominguez; Xuejuan Jiang; David V Conti; Jose Esteban Castelao; Mariana C Stern; Victoria K Cortessis; Malcolm C Pike; Yong-Bing Xiang; Yu-Tang Gao; Jian-Min Yuan; David J Van Den Berg
Journal:  Carcinogenesis       Date:  2010-11-15       Impact factor: 4.944

3.  Quantitative assessment of the influence of common variations (rs8034191 and rs1051730) at 15q25 and lung cancer risk.

Authors:  Bin Hu; Ying Huang; Rong-huan Yu; Hong-ju Mao; Chao Guan; Jing Zhao
Journal:  Tumour Biol       Date:  2013-11-20

4.  CRR9p polymorphism as a protective factor for lung cancer.

Authors:  Yang Chen; Zhiguo Yu; Bo Zhang; Zhengqi Chang; Hong Wang; Zhandi Liu
Journal:  Tumour Biol       Date:  2014-06-24

5.  Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer--a case-control study in a Chinese population.

Authors:  Ajay A Myneni; Shen-Chih Chang; Rungui Niu; Li Liu; Heather M Ochs-Balcom; Yanli Li; Chao Zhang; Baoxing Zhao; Jianping Shi; Xiaoyou Han; Jiawei Li; Jia Su; Lin Cai; Shunzhang Yu; Zuo-Feng Zhang; Lina Mu
Journal:  Lung Cancer       Date:  2013-02-19       Impact factor: 5.705

6.  Association of CRR9 locus with elevated risk of squamous cell carcinoma and basal cell carcinoma.

Authors:  Tao Liu; Li Jiang; Xiaoxing Lv; Jinqing Li; Yuejun Li; Wangzhou Li; Xueyong Li; Jing Li
Journal:  Int J Clin Exp Med       Date:  2015-03-15

7.  Cigarette smoking associated with lung adenocarcinoma in situ in a large case-control study (SFBALCS).

Authors:  Paige M Bracci; Jennette Sison; Helen Hansen; Kyle M Walsh; Charles P Quesenberry; Dan J Raz; Margaret Wrensch; John K Wiencke
Journal:  J Thorac Oncol       Date:  2012-09       Impact factor: 15.609

8.  Quantitative assessment of common genetic variants on chromosome 5p15 and lung cancer risk.

Authors:  Hongyu Wu; Ren Zhu
Journal:  Tumour Biol       Date:  2014-03-12

Review 9.  Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.

Authors:  Mukesh Verma; Muin J Khoury; John P A Ioannidis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-14       Impact factor: 4.254

10.  A rigorous and comprehensive validation: common genetic variations and lung cancer.

Authors:  Ping Yang; Yafei Li; Ruoxiang Jiang; Julie M Cunningham; Yan Li; Fang Zhang; Mariza de Andrade
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.